No Data
No Data
Cardiol Therapeutics Inc.: Financial Update
Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 P.m. EDT
Cardiol Therapeutics Releases Phase II Data Showing CardiolRx Reduces Pericarditis Pain and Inflammation | TSX:CRDL, NASDAQ:CRDL
Cardiol Therapeutics Announces Positive Topline Data From Its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
Sector Spotlight: Orphan Drug Developers With Significant Upside